Mitochondrial membrane lipid remodeling in pathophysiology: A new target for diet and therapeutic interventions

Progress in Lipid Research

Volumn 52, Issue 4, 2013, Pages 513-528

  Monteiro, João P ^a,b   Oliveira, Paulo J ^a   Jurado, Amália S ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Aging; Apoptosis; Cardiolipin; Mitochondrial membrane lipids; Pathology

Indexed keywords

CARDIOLIPIN; CAVEOLIN 1; CHOLESTEROL; CHOLINESTERASE INHIBITOR; CURCUMIN; CYCLOPROPANE; DOXORUBICIN; HALOTHANE; ISOFLURANE; LINOLEIC ACID; MEMBRANE LIPID; METHOXYFLURANE; NIMESULIDE; TETRACAINE;

AGING; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BARTH SYNDROME; CACHEXIA; CANCER CELL; CARDIOTOXICITY; CELL SURVIVAL; DIABETES MELLITUS; DIET THERAPY; HEART DISEASE; HUMAN; LIPID COMPOSITION; LIPID METABOLISM; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL TOXICITY; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; AGING; AIF; APOPTOSIS; APOPTOSIS-INDUCING FACTOR; ATP; BARTH SYNDROME; BTHS; CALCIUM-INDEPENDENT PHOSPHOLIPASE A2Γ; CARDIOLIPIN; CL; CYT C; CYTOCHROME C; DEOXYRIBONUCLEIC ACID; DNA; DOX; DOXORUBICIN; ENDOPLASMIC RETICULUM; ER; GANGLIOSIDE GD3; GD3; IMM; INNER MITOCHONDRIAL MEMBRANE; IPLA2Γ; MAM; MITOCHONDRIA-ASSOCIATED MEMBRANE; MITOCHONDRIAL DNA; MITOCHONDRIAL MEMBRANE LIPIDS; MITOCHONDRIAL PERMEABILITY TRANSITION; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MLCL; MONOLYSOCARDIOLIPIN; MPT; MTDNA; OMM; OUTER MITOCHONDRIAL MEMBRANE; PATHOLOGY; PC; PE; PG; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PI; POLYUNSATURATED FATTY ACID; PS; PTP; PUFA; REACTIVE OXYGEN SPECIES; ROS; SECOND MITOCHONDRIA-DERIVED ACTIVATOR OF CASPASES/DIRECT IAP BINDING PROTEIN WITH LOW PI; SMAC/DIABLO; UCP; UNCOUPLING PROTEIN;

BARTH SYNDROME; CARDIOLIPINS; CHOLESTEROL; HEART DISEASES; HUMANS; MEMBRANE LIPIDS; METABOLIC DISEASES; MITOCHONDRIA; NEOPLASMS; PARKINSON DISEASE;

EID: 84884316964     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2013.06.002     Document Type: Review

References (256)

1. L. Sagan On the origin of mitosing cells. 1967 J NIH Res 5 1993 65 72
2. T.M. Embley, and W. Martin Eukaryotic evolution, changes and challenges Nature 440 2006 623 630
3. S. Mackenzie, and L. McIntosh Higher plant mitochondria Plant Cell 11 1999 571 586
4. G.C. Vanlerberghe Alternative oxidase: a mitochondrial respiratory pathway to maintain metabolic and signaling homeostasis during abiotic and biotic stress in plants Int J Mol Sci 14 2013 6805 6847
5. A.H. Millar, J. Whelan, K.L. Soole, and D.A. Day Organization and regulation of mitochondrial respiration in plants Annu Rev Plant Biol 62 2011 79 104
6. A.E. McDonald, and G.C. Vanlerberghe Origins, evolutionary history, and taxonomic distribution of alternative oxidase and plastoquinol terminal oxidase Comp Biochem Physiol Part D Genomics Proteomics 1 2006 357 364
7. Y. Kushnareva, and D.D. Newmeyer Bioenergetics and cell death Ann NY Acad Sci 1201 2010 50 57
8. P. Mitchell Chemiosmotic coupling in oxidative and photosynthetic phosphorylation Biochim Biophys Acta Bioenerg 1807 2011 1507 1538
9. P.D. Boyer The ATP synthase - a splendid molecular machine Annu Rev Biochem 66 1997 717 749
10. S. Papa Mitochondrial oxidative phosphorylation changes in the life span. Molecular aspects and physiopathological implications Biochim Biophys Acta Bioenerg 1276 1996 87 105
11. M.R. Duchen, and G. Szabadkai Roles of mitochondria in human disease Essays Biochem 47 2010 115 137
12. C. Osman, D.R. Voelker, and T. Langer Making heads or tails of phospholipids in mitochondria J Cell Biol 192 2011 7 16
13. C.D. Stubbs, and A.D. Smith The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function Biochim Biophys Acta - Rev Biomembr 779 1984 89 137
14. J.K. Raison The influence of temperature-induced phase changes on the kinetics of respiratory and other membrane-associated enzyme systems J Bioenerg Biomembr 4 1973 285 309
15. E. Haeffner, and O. Privett Influence of dietary fatty acids on membrane properties and enzyme activities of liver mitochondria of normal and hypophysectomized rats Lipids 10 1975 75 81
16. E.J. McMurchie, and J.K. Raison Membrane lipid fluidity and its effect on the activation energy of membrane-associated enzymes Biochim Biophys Acta Biomembr 554 1979 364 374
17. S.M. Innis, and M.T. Clandinin Dynamic modulation of mitochondrial inner-membrane lipids in rat heart by dietary fat Biochem J 193 1981 155 167
18. S.M. Innis, and M.T. Clandinin Mitochondrial-membrane polar-head-group composition is influenced by diet fat Biochem J 198 1981 231 234
19. R.R. Brenner Effect of unsaturated acids on membrane structure and enzyme kinetics Prog Lipid Res 23 1984 69 96
20. J.P. Monteiro, C.V. Pereira, A.M. Silva, E. Maciel, I. Baldeiras, and F. Peixoto Rapeseed oil-rich diet alters hepatic mitochondrial membrane lipid composition and disrupts bioenergetics Arch Toxicol 2013 in press. http://dx.doi.org/10.1016/j.plipres.2013.06.002
21. S. Yamaoka, R. Urade, and M. Kito Mitochondrial function in rats is affected by modification of membrane phospholipids with dietary sardine oil J Nutr 118 1988 290 296
22. M.D. Brand, P. Couture, and A.J. Hulbert Liposomes from mammalian liver mitochondria are more polyunsaturated and leakier to protons than those from reptiles Comp Biochem Physiol B Biochem Mol Biol 108 1994 181 188
23. V. Barzanti, M. Battino, A. Baracca, M. Cavazzoni, M. Cocchi, and R. Noble The effect of dietary lipid changes on the fatty acid composition and function of liver, heart and brain mitochondria in the rat at different ages Br J Nutr 71 1994 193 202
24. M.D. Brand, P. Couture, P.L. Else, K.W. Withers, and A.J. Hulbert Evolution of energy metabolism. Proton permeability of the inner membrane of liver mitochondria is greater in a mammal than in a reptile Biochem J 275 1991 81 86
25. M.D. Brand, L.F. Chien, E.K. Ainscow, D.F. Rolfe, and R.K. Porter The causes and functions of mitochondrial proton leak Biochim Biophys Acta 1187 1994 132 139
26. P.S. Brookes, J.A. Buckingham, A.M. Tenreiro, A.J. Hulbert, and M.D. Brand The proton permeability of the inner membrane of liver mitochondria from ectothermic and endothermic vertebrates and from obese rats: correlations with standard metabolic rate and phospholipid fatty acid composition Comp Biochem Physiol B Biochem Mol Biol 119 1998 325 334
27. M.T. Clandinin, C.J. Field, K. Hargreaves, L. Morson, and E. Zsigmond Role of diet fat in subcellular structure and function Can J Physiol Pharmacol 63 1985 546 556
28. E.A. Dahlhoff, and G.N. Somero Effects of temperature on mitochondria from abalone (Genus haliotis): adaptative plsaticity and its limits J Exp Biol 185 1993 151 168
29. M.E. Vázquez-Memije, M.J. Cárdenas-Méndez, A. Tolosa, and M.E. Hafidi Respiratory chain complexes and membrane fatty acids composition in rat testis mitochondria throughout development and ageing Exp Gerontol 40 2005 482 490
30. 2 production in liver Comp Biochem Physiol B Biochem Mol Biol 140 2005 99 108
31. 2+-induced permeability transition J Mol Cell Cardiol 47 2009 819 827
32. K. Pfeiffer, V. Gohil, R.A. Stuart, C. Hunte, U. Brandt, and M.L. Greenberg Cardiolipin stabilizes respiratory chain supercomplexes J Biol Chem 278 2003 52873 52880
33. F. Gonzalvez, and E. Gottlieb Cardiolipin: setting the beat of apoptosis Apoptosis 12 2007 877 885
34. S.M. Claypool Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function Biochim Biophys Acta Biomembr 1788 2009 2059 2068
35. K.W.J. Wahle Fatty acid modification and membrane lipids Proc Nutr Soc 42 1983 273 287
36. V.M. Gohil, and M.L. Greenberg Mitochondrial membrane biogenesis: phospholipids and proteins go hand in hand J Cell Biol 184 2009 469 472
37. Z. Huang, J. Jiang, V.A. Tyurin, Q. Zhao, A. Mnuskin, and J. Ren Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis Free Radic Biol Med 44 2008 1935 1944
38. F. Jiang, H.S. Rizavi, and M.L. Greenberg Cardiolipin is not essential for the growth of Saccharomyces cerevisiae on fermentable or non-fermentable carbon sources Mol Microbiol 26 1997 481 491
39. T. Ohtsuka, M. Nishijima, and Y. Akamatsu A somatic cell mutant defective in phosphatidylglycerophosphate synthase, with impaired phosphatidylglycerol and cardiolipin biosynthesis J Biol Chem 268 1993 22908 22913
40. A. Nadal-Casellas, E. Amengual-Cladera, A.M. Proenza, I. Llado, and M. Gianotti Long-term high-fat-diet feeding impairs mitochondrial biogenesis in liver of male and female rats Cell Physiol Biochem 26 2010 291 302
41. C.L. Kien Dietary interventions for metabolic syndrome: role of modifying dietary fats Curr Diab Rep 9 2009 43 50
42. F.H. Igney, and P.H. Krammer Death and anti-death: tumour resistance to apoptosis Nat Rev Cancer 2 2002 277 288
43. N.N. Danial, and S.J. Korsmeyer Cell death: critical control points Cell 116 2004 205 219
44. G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial membrane permeabilization in cell death Physiol Rev 87 2007 99 163
45. P. Bernardi, A. Krauskopf, E. Basso, V. Petronilli, E. Blalchy-Dyson, and F. Di Lisa The mitochondrial permeability transition from in vitro artifact to disease target FEBS J 273 2006 2077 2099
46. V. Skulachev Bioenergetic aspects of apoptosis, necrosis and mitoptosis Apoptosis 11 2006 473 485
47. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
48. M. Crimi, and M.D. Esposti Apoptosis-induced changes in mitochondrial lipids Biochim Biophys Acta Mol Cell Res 1813 2011 551 557
49. M. Degli Esposti, I.M. Cristea, S.J. Gaskell, Y. Nakao, and C. Dive Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death Cell Death Differ 10 2003 1300 1309
50. I.M. Cristea, and M. Degli Esposti Membrane lipids and cell death: an overview Chem Phys Lipids 129 2004 133 160
51. V.E. Kagan, A. Bayir, H. Bayir, D. Stoyanovsky, G.G. Borisenko, and Y.Y. Tyurina Mitochondria-targeted disruptors and inhibitors of cytochrome c/cardiolipin peroxidase complexes: a new strategy in anti-apoptotic drug discovery Mol Nutr Food Res 53 2009 104 114
52. V.E. Kagan, V.A. Tyurin, J. Jiang, Y.Y. Tyurina, V.B. Ritov, and A.A. Amoscato Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors Nat Chem Biol 1 2005 223 232
53. V.E. Kagan, H.A. Bayir, N.A. Belikova, O. Kapralov, Y.Y. Tyurina, and V.A. Tyurin Cytochrome c/cardiolipin relations in mitochondria: a kiss of death Free Radic Biol Med 46 2009 1439 1453
54. L.V. Basova, I.V. Kurnikov, L. Wang, V.B. Ritov, N.A. Belikova, and I.I. Vlasova Cardiolipin switch in mitochondria: shutting off the reduction of cytochrome c and turning on the peroxidase activity Biochemistry 46 2007 3423 3434
55. F. Gonzalvez, and E. Gottlieb Cardiolipin: setting the beat of apoptosis Apoptosis 12 2007 877 885
56. M. Sorice, V. Manganelli, P. Matarrese, A. Tinari, R. Misasi, and W. Malorni Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria FEBS Lett 583 2009 2447 2450
57. C.R. Gault, L.M. Obeid, and Y.A. Hannun An overview of sphingolipid metabolism: from synthesis to breakdown Adv Exp Med Biol 688 2010 1 23
58. C. Bionda, J. Portoukalian, D. Schmitt, C. Rodriguez-Lafrasse, and D. Ardail Subcellular compartmentalization of ceramide metabolism: MAM (mitochondria-associated membrane) and/or mitochondria? Biochem J 382 2004 527 533
59. L.J. Siskind Mitochondrial ceramide and the induction of apoptosis J Bioenerg Biomembr 37 2005 143 153
60. L.J. Siskind, R.N. Kolesnick, and M. Colombini Ceramide forms channels in mitochondrial outer membranes at physiologically relevant concentrations Mitochondrion 6 2006 118 125
61. H. Lee, J.A. Rotolo, J. Mesicek, T. Penate-Medina, A. Rimner, and W.-C. Liao Mitochondrial ceramide-rich macrodomains functionalize Bax upon irradiation PLoS One 6 2011 e19783
62. L. Silva, R.F. de Almeida, A. Fedorov, A.P. Matos, and M. Prieto Ceramide-platform formation and -induced biophysical changes in a fluid phospholipid membrane Mol Membr Biol 23 2006 137 148
63. H. Grassme, J. Riethmuller, and E. Gulbins Biological aspects of ceramide-enriched membrane domains Prog Lipid Res 46 2007 161 170
64. J.E. Chipuk, G.P. McStay, A. Bharti, T. Kuwana, C.J. Clarke, and L.J. Siskind Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis Cell 148 2012 988 1000
65. M. Sorice, P. Matarrese, A. Tinari, A.M. Giammarioli, T. Garofalo, and V. Manganelli Raft component GD3 associates with tubulin following CD95/Fas ligation FASEB J 23 2009 3298 3308
66. T. Garofalo, A.M. Giammarioli, R. Misasi, A. Tinari, V. Manganelli, and L. Gambardella Lipid microdomains contribute to apoptosis-associated modifications of mitochondria in T cells Cell Death Differ 12 2005 1378 1389
67. L.J. Pike The challenge of lipid rafts J Lipid Res 50 2009 S323 S328
68. W. Malorni, A. Giammarioli, T. Garofalo, and M. Sorice Dynamics of lipid raft components during lymphocyte apoptosis: the paradigmatic role of GD3 Apoptosis 12 2007 941 949
69. A.M. Verhagen, P.G. Ekert, M. Pakusch, J. Silke, L.M. Connolly, and G.E. Reid Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins Cell 102 2000 43 53
70. O. Warburg On the origin of cancer cells Science 123 1956 309 314
71. I.A. Barbosa, N.G. Machado, A.J. Skildum, P.M. Scott, and P.J. Oliveira Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies Biochim Biophys Acta 1826 2012 238 254
72. L. Galluzzi, E. Morselli, O. Kepp, I. Vitale, A. Rigoni, and E. Vacchelli Mitochondrial gateways to cancer Mol Aspects Med 31 2010 1 20
73. J.S. Modica-Napolitano, M. Kulawiec, and K.K. Singh Mitochondria and human cancer Curr Mol Med 7 2007 121 131
74. L.G. Baggetto, and R. Testa-Parussini Role of acetoin on the regulation of intermediate metabolism of Ehrlich ascites tumor mitochondria: its contribution to membrane cholesterol enrichment modifying passive proton permeability Arch Biochem Biophys 283 1990 241 248
75. J. Montero, A. Morales, L. Llacuna, J.M. Lluis, O. Terrones, and G. Basanez Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma Cancer Res 68 2008 5246 5256
76. A.M. Campbell, A. Capuano, and S.H. Chan A cholesterol-binding and transporting protein from rat liver mitochondria Biochim Biophys Acta 1567 2002 123 132
77. M.A. Kiebish, X. Han, H. Cheng, J.H. Chuang, and T.N. Seyfried Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer J Lipid Res 49 2008 2545 2556
78. M.A. Kiebish, X. Han, H. Cheng, and T.N. Seyfried In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours ASN Neuro 1 3 2009 pii: e00011
79. R. Morton, C. Cunningham, R. Jester, M. Waite, N. Miller, and H.P. Morris Alteration of mitochondrial function and lipid composition in Morris 7777 hepatoma Cancer Res 36 1976 3246 3254
80. F. Lopez-Rios, M. Sanchez-Arago, E. Garcia-Garcia, A.D. Ortega, J.R. Berrendero, and F. Pozo-Rodriguez Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas Cancer Res 67 2007 9013 9017
81. H.K. Kim, W.S. Park, S.H. Kang, M. Warda, N. Kim, and J.H. Ko Mitochondrial alterations in human gastric carcinoma cell line Am J Physiol Cell Physiol 293 2007 C761 C771
82. F. Weinberg, R. Hamanaka, W.W. Wheaton, S. Weinberg, J. Joseph, and M. Lopez Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity Proc Natl Acad Sci USA 107 2010 8788 8793
83. M. Calvani, G. Comito, E. Giannoni, and P. Chiarugi Time-dependent stabilization of hypoxia inducible factor-1alpha by different intracellular sources of reactive oxygen species PLoS One 7 2012 e38388
84. L. Sanchez-Cenizo, L. Formentini, M. Aldea, A.D. Ortega, P. Garcia-Huerta, and M. Sanchez-Arago Up-regulation of the ATPase inhibitory factor 1 (IF1) of the mitochondrial H+-ATP synthase in human tumors mediates the metabolic shift of cancer cells to a Warburg phenotype J Biol Chem 285 2010 25308 25313
85. P.W. Ho, J.W. Ho, H.M. Tse, D.H. So, D.C. Yiu, and H.F. Liu Uncoupling protein-4 (UCP4) increases ATP supply by interacting with mitochondrial Complex II in neuroblastoma cells PLoS One 7 2012 e32810
86. D. Robbins, and Y. Zhao New aspects of mitochondrial uncoupling proteins (UCPs) and their roles in tumorigenesis Int J Mol Sci 12 2011 5285 5293
87. V. Ayyasamy, K.M. Owens, M.M. Desouki, P. Liang, A. Bakin, and K. Thangaraj Cellular model of Warburg effect identifies tumor promoting function of UCP2 in breast cancer and its suppression by genipin PLoS One 6 2011 e24792
88. A.M. Campbell, and S.H. Chan Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect J Bioenerg Biomembr 40 2008 193 197
89. M. Bosch, M. Mari, A. Herms, A. Fernandez, A. Fajardo, and A. Kassan Caveolin-1 deficiency causes cholesterol-dependent mitochondrial dysfunction and apoptotic susceptibility Curr Biol 21 2011 681 686
90. T. Friedrich, B. Richter, T. Gaiser, C. Weiss, K.P. Janssen, and H. Einwaechter Deficiency of caveolin-1 in Apcmin/+ mice promotes colorectal tumorigenesis Carcinogenesis 2013 in press. http://dx.doi.org/10.1093/carcin/ bgt142
91. -/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts Am J Pathol 174 2009 746 761
92. G. Bonuccelli, D. Whitaker-Menezes, R. Castello-Cros, S. Pavlides, R.G. Pestell, and A. Fatatis The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts Cell Cycle 9 2010 1960 1971
93. V.E. Jahnke, O. Sabido, A. Defour, J. Castells, E. Lefai, and D. Roussel Evidence for mitochondrial respiratory deficiency in rat rhabdomyosarcoma cells PLoS One 5 2010 e8637
94. J.F. Dumas, C. Goupille, C.M. Julienne, M. Pinault, S. Chevalier, and P. Bougnoux Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis J Hepatol 54 2011 320 327
95. M.A. Kiebish, X. Han, H. Cheng, J.H. Chuang, and T.N. Seyfried Brain mitochondrial lipid abnormalities in mice susceptible to spontaneous gliomas Lipids 43 2008 951 959
96. I.N. Todor, N.Y. Lukyanova, and V.F. Chekhun The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells Exp Oncol 34 2012 97 100
97. S.Y. Choi, F. Gonzalvez, G.M. Jenkins, C. Slomianny, D. Chretien, and D. Arnoult Cardiolipin deficiency releases cytochrome c from the inner mitochondrial membrane and accelerates stimuli-elicited apoptosis Cell Death Differ 14 2007 597 606
98. D.B. Ostrander, G.C. Sparagna, A.A. Amoscato, J.B. McMillin, and W. Dowhan Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis J Biol Chem 276 2001 38061 38067
99. F. Abel, R.M. Sjoberg, S. Nilsson, P. Kogner, and T. Martinsson Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology Eur J Cancer 41 2005 635 646
100. M. Kurtoglu, and T.J. Lampidis From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors Mol Nutr Food Res 53 2009 68 75
101. L.W. Jones, K.S. Narayan, C.E. Shapiro, and T.W. Sweatman Rhodamine-123: therapy for hormone refractory prostate cancer, a phase I clinical trial J Chemother 17 2005 435 440
102. J.S. Modica-Napolitano, and J.R. Aprille Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells Adv Drug Deliv Rev 49 2001 63 70
103. S.K. Powers, and K. Ellington Selective retention of rhodamine-123 by malignant glioma in the rat J Neurooncol 6 1988 343 347
104. J.L. Chunta, K.S. Vistisen, Z. Yazdi, and R.D. Braun Uptake rate of cationic mitochondrial inhibitor MKT-077 determines cellular oxygen consumption change in carcinoma cells PLoS One 7 2012 e37471
105. D.J. Propper, J.P. Braybrooke, D.J. Taylor, R. Lodi, P. Styles, and J.A. Cramer Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours Ann Oncol 10 1999 923 927
106. T.J. Lampidis, Y. Hasin, M.J. Weiss, and L.B. Chen Selective killing of carcinoma cells "in vitro" by lipophilic-cationic compounds: a cellular basis Biomed Pharmacother 39 1985 220 226
107. G.C. Pereira, A.F. Branco, J.A. Matos, S.L. Pereira, D. Parke, and E.L. Perkins Mitochondrially targeted effects of berberine [Natural Yellow 18, 5,6-dihydro-9,10-dimethoxybenzo(g)-1,3-benzodioxolo(5,6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions J Pharmacol Exp Ther 323 2007 636 649
108. T.L. Serafim, P.J. Oliveira, V.A. Sardao, E. Perkins, D. Parke, and J. Holy Different concentrations of berberine result in distinct cellular localization patterns and cell cycle effects in a melanoma cell line Cancer Chemother Pharmacol 61 2008 1007 1018
109. V. Gogvadze, S. Orrenius, and B. Zhivotovsky Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18 2008 165 173
110. A.J. Chicco, and G.C. Sparagna Role of cardiolipin alterations in mitochondrial dysfunction and disease Am J Physiol Cell Physiol 292 2007 C33 C44
111. M. Schlame, and M. Ren Barth syndrome, a human disorder of cardiolipin metabolism FEBS Lett 580 2006 5450 5455
112. D.J. Mancuso, H.F. Sims, X. Han, C.M. Jenkins, S.P. Guan, and K. Yang Genetic ablation of calcium-independent phospholipase A2-gamma leads to alterations in mitochondrial lipid metabolism and function resulting in a deficient mitochondrial bioenergetic phenotype J Biol Chem 282 2007 34611 34622
113. G. Paradies, G. Petrosillo, M. Pistolese, and F.M. Ruggiero The effect of reactive oxygen species generated from the mitochondrial electron transport chain on the cytochrome c oxidase activity and on the cardiolipin content in bovine heart submitochondrial particles FEBS Lett 466 2000 323 326
114. G. Petrosillo, N. Di Venosa, F.M. Ruggiero, M. Pistolese, D. D'Agostino, and E. Tiravanti Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen tension control. Role of oxygen-free radicals and cardiolipin Biochim Biophys Acta Bioenerg 1710 2005 78 86
115. G.C. Sparagna, A.J. Chicco, R.C. Murphy, M.R. Bristow, C.A. Johnson, and M.L. Rees Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure J Lipid Res 48 2007 1559 1570
116. S. Bione, P. D'Adamo, E. Maestrini, A.K. Gedeon, P.A. Bolhuis, and D. Toniolo A novel X-linked gene, G4.5. is responsible for Barth syndrome Nat Genet 12 1996 385 389
117. M. Schlame, R.I. Kelley, A. Feigenbaum, J.A. Towbin, P.M. Heerdt, and T. Schieble Phospholipid abnormalities in children with Barth syndrome J Am Coll Cardiol 42 2003 1994 1999
118. P.G. Barth, F. Valianpour, V.M. Bowen, J. Lam, M. Duran, and F.M. Vaz X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): an update Am J Med Genet A 126A 2004 349 354
119. R.I. Kelley, J.P. Cheatham, B.J. Clark, M.A. Nigro, B.R. Powell, and G.W. Sherwood X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria J Pediatr 119 1991 738 747
120. P.G. Barth, H.R. Scholte, J.A. Berden, J.M. Van der Klei-Van Moorsel, I.E. Luyt-Houwen, and E.T. Van 't Veer-Korthof An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes J Neurol Sci 62 1983 327 355
121. A.F. Neuwald Barth syndrome may be due to an acyltransferase deficiency Curr Biol 7 1997 R465 R466
122. Y. Xu, J.J. Sutachan, H. Plesken, R.I. Kelley, and M. Schlame Characterization of lymphoblast mitochondria from patients with Barth syndrome Lab Invest 85 2005 823 830
123. P.G. Barth, C. Van den Bogert, P.A. Bolhuis, H.R. Scholte, A.H. van Gennip, and R.B. Schutgens X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts J Inherit Metab Dis 19 1996 157 160
124. S.M. Claypool Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function Biochim Biophys Acta 1788 2009 2059 2068
125. P. Vreken, F. Valianpour, L.G. Nijtmans, L.A. Grivell, B. Plecko, and R.J. Wanders Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome Biochem Biophys Res Commun 279 2000 378 382
126. M. Schlame, J.A. Towbin, P.M. Heerdt, R. Jehle, S. DiMauro, and T.J. Blanck Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome Ann Neurol 51 2002 634 637
127. M. Schlame Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes J Lipid Res 49 2008 1607 1620
128. C.G. Steward, R.A. Newbury-Ecob, R. Hastings, S.F. Smithson, B. Tsai-Goodman, and O.W. Quarrell Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth Prenat Diagn 30 2010 970 976
129. A. Malhotra, I. Edelman-Novemsky, Y. Xu, H. Plesken, J. Ma, and M. Schlame Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome Proc Natl Acad Sci USA 106 2009 2337 2341
130. M. Schlame, D. Acehan, B. Berno, Y. Xu, S. Valvo, and M. Ren The physical state of lipid substrates provides transacylation specificity for tafazzin Nat Chem Biol 8 2012 862 869
131. A. Malhotra, Y. Xu, M. Ren, and M. Schlame Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species Biochim Biophys Acta 1791 2009 314 320
132. Y. Xu, A. Malhotra, M. Ren, and M. Schlame The enzymatic function of tafazzin J Biol Chem 281 2006 39217 39224
133. M. Schlame Cardiolipin remodeling and the function of tafazzin Biochim Biophys Acta 1831 2013 582 588
134. A.I. ToleÄkis, A.I. Dagis, and A.K. Prashkiavichius Effect of myocardial ischemia on the phospholipid composition of cardiac tissue and mitochondria Vopr Med Khim 28 1982 64 67
135. S.C. Vasdev, G.P. Biro, R. Narbaitz, and K.J. Kako Membrane changes induced by early myocardial ischemia in the dog Can J Biochem 58 1980 1112 1129
136. Q. Chen, and E.J. Lesnefsky Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain Free Radic Biol Med 40 6 2006 976 982
137. B. O'Rourke, and D.K. Reibel Effects of adrenoceptor blockade on cardiac hypertrophy and myocardial phospholipids Proc Soc Exp Biol Med 200 1992 95 100
138. D.K. Reibel, B. O'Rourke, K.A. Foster, H. Hutchinson, C.E. Uboh, and R.L. Kent Altered phospholipid metabolism in pressure-overload hypertrophied hearts Am J Physiol Heart Circ Physiol 250 1986 H1 H6
139. K. Okumura, Y. Yamada, J. Kondo, H. Hashimoto, T. Ito, and J. Kitoh Decreased 1,2-diacylglycerol levels in myopathic hamster hearts during the development of heart failure J Mol Cell Cardiol 23 1991 409 416
140. G.C. Sparagna, and E.J. Lesnefsky Cardiolipin remodeling in the heart J Cardiovasc Pharmacol 53 2009 290 301
141. X. Han, J. Yang, H. Cheng, K. Yang, D.R. Abendschein, and R.W. Gross Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction Biochemistry 44 2005 16684 16694
142. M.A. Kiebish, K. Yang, H.F. Sims, C.M. Jenkins, X. Liu, and D.J. Mancuso Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency J Biol Chem 287 2012 25086 25097
143. G. Paradies, F.M. Ruggiero, G. Petrosillo, and E. Quagliariello Stimulation of carnitine acylcarnitine translocase activity in heart mitochondria from hyperthyroid rats FEBS Lett 397 1996 260 262
144. S.G. Cao, P. Cheng, A. Angel, and G.M. Hatch Thyroxine stimulates phosphatidylglycerolphosphate synthase activity in rat heart mitochondria Biochim Biophys Acta 1256 1995 241 244
145. G. Paradies, and F.M. Ruggiero Effect of hyperthyroidism on the transport of pyruvate in rat-heart mitochondria Biochim Biophys Acta Bioenerg 935 1988 79 86
146. G. Paradies, and F.M. Ruggiero Stimulation of phosphate transport in rat-liver mitochondria by thyroid hormones Biochim Biophys Acta Bioenerg 1019 1990 133 136
147. W. Taylor, F. Xu, B. Ma, T. Mutter, V. Dolinsky, and G. Hatch Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart BMC Biochem 3 2002 9
148. G. Petrosillo, P. Portincasa, I. Grattagliano, G. Casanova, M. Matera, and F.M. Ruggiero Mitochondrial dysfunction in rat with nonalcoholic fatty liver: involvement of complex I, reactive oxygen species and cardiolipin Biochim Biophys Acta Bioenerg 1767 2007 1260 1267
149. C.E. Ellis, E.J. Murphy, D.C. Mitchell, M.Y. Golovko, F. Scaglia, and G.C. Barcelo-Coblijn Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein Mol Cell Biol 25 2005 10190 10201
150. S. Lucia, M. Esposito, F. Rossi Fanelli, and M. Muscaritoli Cancer cachexia: from molecular mechanisms to patient's care Crit Rev Oncog 17 2012 315 321
151. J.F. Dumas, L. Peyta, C. Couet, and S. Servais Implication of liver cardiolipins in mitochondrial energy metabolism disorder in cancer cachexia Biochimie 95 2013 27 32
152. G.C. Pereira, S.P. Pereira, C.V. Pereira, J.A. Lumini, J. Magalhaes, and A. Ascensao Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specific PLoS One 7 2012 e38867
153. G.C. Pereira, A.M. Silva, C.V. Diogo, F.S. Carvalho, P. Monteiro, and P.J. Oliveira Drug-induced cardiac mitochondrial toxicity and protection: from doxorubicin to carvedilol Curr Pharm Des 17 2011 2113 2129
154. K.B. Wallace Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis Cardiovasc Toxicol 7 2007 101 107
155. E.J. Demant Inactivation of cytochrome c oxidase activity in mitochondrial membranes during redox cycling of doxorubicin Biochem Pharmacol 41 1991 543 552
156. K. Kashfi, M. Israel, T.W. Sweatman, R. Seshadri, and G.A. Cook Inhibition of mitochondrial carnitine palmitoyltransferases by adriamycin and adriamycin analogues Biochem Pharmacol 40 1990 1441 1448
157. K. Nicolay, and B. de Kruijff Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV Biochim Biophys Acta 892 1987 320 330
158. E. Goormaghtigh, G. Pollakis, and J.M. Ruysschaert Mitochondrial membrane modifications induced by adriamycin-mediated electron transport Biochem Pharmacol 32 1983 889 893
159. E. Goormaghtigh, R. Brasseur, and J.M. Ruysschaert Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment Biochem Biophys Res Commun 104 1982 314 320
160. E. Goormaghtigh, P. Chatelain, J. Caspers, and J.M. Ruysschaert Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity Biochem Pharmacol 29 1980 3003 3010
161. T. Melo, R.A. Videira, S. Andre, E. Maciel, C.S. Francisco, and A.M. Oliveira-Campos Tacrine and its analogues impair mitochondrial function and bioenergetics: a lipidomic analysis in rat brain J Neurochem 120 2012 998 1013
162. J.P. Monteiro, A.F. Martins, M. Lucio, S. Reis, T.J. Pinheiro, and C.F. Geraldes Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity? Toxicol In Vitro 25 2011 1215 1223
163. J.P. Monteiro, A.F. Martins, M. Lucio, S. Reis, C.F. Geraldes, and P.J. Oliveira Interaction of carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) with lipid membrane systems: a biophysical approach with relevance to mitochondrial uncoupling J Bioenerg Biomembr 43 2011 287 298
164. J.P. Monteiro, A.F. Martins, C. Nunes, C.M. Morais, M. Lucio, and S. Reis A biophysical approach to menadione membrane interactions: relevance for menadione-induced mitochondria dysfunction and related deleterious/therapeutic effects Biochim Biophys Acta 1828 2013 1899 1908
165. C. Garcia-Ruiz, M. Mari, A. Colell, A. Morales, F. Caballero, and J. Montero Mitochondrial cholesterol in health and disease Histol Histopathol 24 2009 117 132
166. E.A. Schon, and E. Area-Gomez Mitochondria-associated ER membranes in Alzheimer disease Mol Cell Neurosci 55 2013 26-26
167. T. Hayashi, R. Rizzuto, G. Hajnoczky, and T.P. Su MAM: more than just a housekeeper Trends Cell Biol 19 2009 81 88
168. E. Winkler, F. Kamp, J. Scheuring, A. Ebke, A. Fukumori, and H. Steiner Generation of Alzheimer disease-associated amyloid beta42/43 peptide by gamma-secretase can be inhibited directly by modulation of membrane thickness J Biol Chem 287 2012 21326 21334
169. M. Fujimoto, T. Hayashi, and T.P. Su The role of cholesterol in the association of endoplasmic reticulum membranes with mitochondria Biochem Biophys Res Commun 417 2012 635 639
170. P.G. Frank, M.W. Cheung, S. Pavlides, G. Llaverias, D.S. Park, and M.P. Lisanti Caveolin-1 and regulation of cellular cholesterol homeostasis Am J Physiol Heart Circ Physiol 291 2006 H677 H686
171. M. Bosch, M. Mari, S.P. Gross, J.C. Fernandez-Checa, and A. Pol Mitochondrial cholesterol: a connection between caveolin, metabolism, and disease Traffic 12 2011 1483 1489
172. D. Harman Aging: a theory based on free radical and radiation chemistry J Gerontol 11 1956 298 300
173. L.A. Loeb, D.C. Wallace, and G.M. Martin The mitochondrial theory of aging and its relationship to reactive oxygen species damage and somatic mtDNA mutations Proc Natl Acad Sci USA 102 2005 18769 18770
174. S. Salvioli, M. Bonafe, M. Capri, D. Monti, and C. Franceschi Mitochondria, aging and longevity - a new perspective FEBS Lett 492 2001 9 13
175. J. Shen, and J. Tower Programmed cell death and apoptosis in aging and life span regulation Discov Med 8 2009 223 226
176. R. Pamplona, G. Barja, and M. Portero-Otin Membrane fatty acid unsaturation, protection against oxidative stress, and maximum life span: a homeoviscous-longevity adaptation? Ann NY Acad Sci 959 2002 475 490
177. R. Gredilla, and G. Barja Minireview: the role of oxidative stress in relation to caloric restriction and longevity Endocrinology 146 2005 3713 3717
178. J. Wanagat, D.B. Allison, and R. Weindruch Caloric intake and aging: mechanisms in rodents and a study in nonhuman primates Toxicol Sci 52 1999 35 40
179. B.P. Yu, B.O. Lim, and M. Sugano Dietary restriction downregulates free radical and lipid peroxide production: plausible mechanism for elongation of life span J Nutr Sci Vitaminol (Tokyo) 48 2002 257 264
180. J. Lee, B.P. Yu, and J.T. Herlihy Modulation of cardiac mitochondrial membrane fluidity by age and calorie intake Free Radic Biol Med 26 1999 260 265
181. J. Venkatraman, and G. Fernandes Modulation of age-related alterations in membrane composition and receptor-associated immune functions by food restriction in Fischer 344 rats Mech Ageing Dev 63 1992 27 44
182. M.T. Tacconi, L. Lligona, M. Salmona, N. Pitsikas, and S. Algeri Aging and food restriction: effect on lipids of cerebral cortex Neurobiol Aging 12 1991 55 59
183. B.N. Ames, M.K. Shigenaga, and T.M. Hagen Mitochondrial decay in aging Biochim Biophys Acta 1271 1995 165 170
184. K. Beyer, and M. Klingenberg ADP/ATP carrier protein from beef heart mitochondria has high amounts of tightly bound cardiolipin, as revealed by 31P nuclear magnetic resonance Biochemistry 24 1985 3821 3826
185. F. Bisaccia, A. De Palma, G. Prezioso, and F. Palmieri Kinetic characterization of the reconstituted tricarboxylate carrier from rat liver mitochondria Biochim Biophys Acta 1019 1990 250 256
186. F. Bisaccia, and F. Palmieri Specific elution from hydroxylapatite of the mitochondrial phosphate carrier by cardiolipin Biochim Biophys Acta - Bioenerg 766 1984 386 394
187. M.S. Sharpley, R.J. Shannon, F. Draghi, and J. Hirst Interactions between phospholipids and NADH: ubiquinone oxidoreductase (complex I) from bovine mitochondria Biochemistry 45 2005 241 248
188. C. Lange, J.H. Nett, B.L. Trumpower, and C. Hunte Specific roles of protein-phospholipid interactions in the yeast cytochrome bc1 complex structure EMBO J 20 2001 6591 6600
189. K. Shinzawa-Itoh, H. Aoyama, K. Muramoto, H. Terada, T. Kurauchi, and Y. Tadehara Structures and physiological roles of 13 integral lipids of bovine heart cytochrome c oxidase EMBO J 26 2007 1713 1725
190. M. Fry, and D.E. Green Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain J Biol Chem 256 1981 1874 1880
191. N.C. Robinson Functional binding of cardiolipin to cytochrome c oxidase J Bioenerg Biomembr 25 1993 153 163
192. M. Zhang, E. Mileykovskaya, and W. Dowhan Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria J Biol Chem 280 2005 29403 29408
193. H. Schägger Respiratory chain supercomplexes of mitochondria and bacteria Biochim Biophys Acta - Bioenerg 1555 2002 154 159
194. B.N. Ames, and J. Liu Delaying the mitochondrial decay of aging with acetylcarnitine Ann NY Acad Sci 1033 2004 108 116
195. G. Paradies, and F.M. Ruggiero Age-related changes in the activity of the pyruvate carrier and in the lipid composition in rat-heart mitochondria Biochim Biophys Acta 1016 1990 207 212
196. G. Petrosillo, V. De Benedictis, F.M. Ruggiero, and G. Paradies Decline in cytochrome c oxidase activity in rat-brain mitochondria with aging. Role of peroxidized cardiolipin and beneficial effect of melatonin J Bioenerg Biomembr 2013
197. 2+ activation of PDH Am J Physiol Heart Circ Physiol 276 1999 H149 H158
198. A. Maftah, M.H. Ratinaud, M. Dumas, F. Bonte, A. Meybeck, and R. Julien Human epidermal cells progressively lose their cardiolipins during ageing without change in mitochondrial transmembrane potential Mech Ageing Dev 77 1994 83 96
199. G. Paradies, F.M. Ruggiero, M.N. Gadaleta, and E. Quagliariello The effect of aging and acetyl-l-carnitine on the activity of the phosphate carrier and on the phospholipid composition in rat heart mitochondria Biochim Biophys Acta 1103 1992 324 326
200. G. Paradies, F.M. Ruggiero, G. Petrosillo, M.N. Gadaleta, and E. Quagliariello Effect of aging and acetyl-l-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria FEBS Lett 350 1994 213 215
201. G. Paradies, F.M. Ruggiero, G. Petrosillo, M.N. Gadaleta, and E. Quagliariello Carnitine-acylcarnitine translocase activity in cardiac mitochondria from aged rats: the effect of acetyl-l-carnitine Mech Ageing Dev 84 1995 103 112
202. G. Paradies, G. Petrosillo, M.N. Gadaleta, and F.M. Ruggiero The effect of aging and acetyl-l-carnitine on the pyruvate transport and oxidation in rat heart mitochondria FEBS Lett 454 1999 207 209
203. S. Moghaddas, M.S. Stoll, P.E. Minkler, R.G. Salomon, C.L. Hoppel, and E.J. Lesnefsky Preservation of cardiolipin content during aging in rat heart interfibrillar mitochondria J Gerontol A Biol Sci Med Sci 57 2002 B22 B28
204. M.B. Lewin, and P.S. Timiras Lipid changes with aging in cardiac mitochondrial membranes Mech Ageing Dev 24 1984 343 351
205. H.J. Lee, J. Mayette, S.I. Rapoport, and R.P. Bazinet Selective remodeling of cardiolipin fatty acids in the aged rat heart Lipids Health Dis 5 2006 2
206. G. Paradies, F.M. Ruggiero, G. Petrosillo, and E. Quagliariello Age-dependent decrease in the cytochrome c oxidase activity and changes in phospholipids in rat-heart mitochondria Arch Gerontol Geriatr 16 1993 263 272
207. M.L. Vorbeck, A.P. Martin, J.W. Long Jr, J.M. Smith, and R.R. Orr Jr Aging-dependent modification of lipid composition and lipid structural order parameter of hepatic mitochondria Arch Biochem Biophys 217 1982 351 361
208. P. Mecocci, M.F. Beal, R. Cecchetti, M.C. Polidori, A. Cherubini, and F. Chionne Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain Mol Chem Neuropathol 31 1997 53 64
209. A.P. Simopoulos Omega-3 fatty acids in inflammation and autoimmune diseases J Am Coll Nutr 21 2002 495 505
210. J.N. Din, D.E. Newby, and A.D. Flapan Omega 3 fatty acids and cardiovascular disease - fishing for a natural treatment BMJ 328 2004 30 35
211. C.H. Ruxton, S.C. Reed, M.J. Simpson, and K.J. Millington The health benefits of omega-3 polyunsaturated fatty acids: a review of the evidence J Hum Nutr Diet 17 2004 449 459
212. P.L. McLennan, M.Y. Abeywardena, and J.S. Charnock The influence of age and dietary fat in an animal model of sudden cardiac death Aust NZ J Med 19 1989 1 5
213. M.L. Burr, J.F. Gilbert, R.M. Holliday, P.C. Elwood, A.M. Fehily, and S. Rogers Effects of change in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial Lancet 334 1989 757 761
214. H.R. Davis, R.T. Bridenstine, D. Vesselinovitch, and R.W. Wissler Fish oil inhibits development of atherosclerosis in rhesus monkeys Arterioscler Throm Vasc Biol 7 1987 441 449
215. D. Kromhout, E.B. Bosschieter, and C. de Lezenne Coulander The inverse relation between fish consumption and 20-year mortality from coronary heart disease N Engl J Med 312 1985 1205 1209
216. P.L. McLennan, M.Y. Abeywardena, and J.S. Charnock Dietary fish oil prevents ventricular fibrillation following coronary artery occlusion and reperfusion Am Heart J 116 1988 709 717
217. B.H. Weiner, I.S. Ockene, P.H. Levine, H.F. Cuénoud, M. Fisher, and B.F. Johnson Inhibition of atherosclerosis by cod-liver oil in a hyperlipidemic swine model N Engl J Med 315 1986 841 846
218. L. Attorri, A. Di Biase, R. Di Benedetto, P. Rigato, A. Di Virgilio, and S. Salvati Micronutrient-enriched rapeseed oils reduce cardiovascular disease risk factors in rats fed a high-fat diet Atherosclerosis 213 2010 422 428
219. C. Nguemeni, B. Delplanque, C. Rovère, N. Simon-Rousseau, C. Gandin, and G. Agnani Dietary supplementation of alpha-linolenic acid in an enriched rapeseed oil diet protects from stroke Pharmacol Res 61 2010 226 233
220. C.P. Caygill, A. Charlett, and M.J. Hill Fat, fish, fish oil and cancer Br J Cancer 74 1996 159 164
221. M. Gonzalez, R. Schemmel, L. Dugan, J. Gray, and C. Welsch Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation Lipids 28 1993 827 832
222. C. Kien Dietary interventions for metabolic syndrome: role of modifying dietary fats Curr Diab Rep 9 2009 43 50
223. U. Spiekerkoetter, J. Bastin, M. Gillingham, A. Morris, F. Wijburg, and B. Wilcken Current issues regarding treatment of mitochondrial fatty acid oxidation disorders J Inherit Metab Dis 33 2010 555 561
224. S. Yamaoka, R. Urade, and M. Kito Cardiolipin molecular species in rat heart mitochondria are sensitive to essential fatty acid-deficient dietary lipids J Nutr 120 1990 415 421
225. M. Aoun, G. Fouret, F. Michel, B. Bonafos, J. Ramos, and J.P. Cristol Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease J Bioenerg Biomembr 44 2012 439 452
226. P.T. Frangopol, and D. Mihailescu Interactions of some local anesthetics and alcohols with membranes Colloids Surf B Biointerfaces 22 2001 3 22
227. A.S. Evers, W.J. Elliott, J.B. Lefkowith, and P. Needleman Manipulation of rat brain fatty acid composition alters volatile anesthetic potency J Clin Invest 77 1986 1028 1033
228. J. Zhang, T. Hadlock, A. Gent, and G.R. Strichartz Tetracaine-membrane interactions: effects of lipid composition and phase on drug partitioning, location, and ionization Biophys J 92 2007 3988 4001
229. J. Barry, M. Fritz, J.R. Brender, P.E.S. Smith, D.-K. Lee, and A. Ramamoorthy Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin J Am Chem Soc 131 2009 4490 4498
230. C. Luxo, A.S. Jurado, J.B.A. Custódio, and V.M. Madeira Use of Bacillus stearothermophilus as a model to study tamoxifen-membrane interactions Toxicol Vitro 10 1996 463 471
231. J.P. Monteiro, J.D. Martins, P.C. Luxo, A.S. Jurado, and V.M.C. Madeira Molecular mechanisms of the metabolite 4-hydroxytamoxifen of the anticancer drug tamoxifen: use of a model microorganism Toxicol Vitro 17 2003 629 634
232. C. Sousa, C. Nunes, M. Lúcio, H. Ferreira, J.L.F.C. Lima, and J. Tavares Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity J Pharm Sci 97 2008 3195 3206
233. J. Monteiro, A. Martins, M. Lúcio, S. Reis, C. Geraldes, and P. Oliveira Interaction of carbonylcyanide p-trifluoromethoxyphenylhydrazone (FCCP) with lipid membrane systems: a biophysical approach with relevance to mitochondrial uncoupling J Bioenerg Biomembr 43 2011 287 298
234. J.P. Monteiro, A.F. Martins, M. Lúcio, S. Reis, T.J.T. Pinheiro, and C.F.G.C. Geraldes Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity? Toxicol Vitro 25 2011 1215 1223
235. M.M. Donato, A.S. Jurado, M.C. Antunes-Madeira, and V.M.C. Madeira Bacillus stearothermophilus as a model to evaluate membrane toxicity of a lipophilic environmental pollutant (DDT) Arch Environ Contam Toxicol 33 1997 109 116
236. J.D. Martins, J.P. Monteiro, M.C. Antunes-Madeira, A.S. Jurado, and V.M.C. Madeira Use of the microorganism Bacillus stearothermophilus as a model to evaluate toxicity of the lipophilic environmental pollutant endosulfan Toxicol Vitro 17 2003 595 601
237. J. Monteiro, R. Videira, M. Matos, A. Dinis, and A. Jurado Non-selective toxicological effects of the insect juvenile hormone analogue methoprene. A membrane biophysical approach Appl Biochem Biotechnol 150 2008 243 257
238. C. Nunes, C. Sousa, H. Ferreira, M. Lucio, J.L. Lima, and J. Tavares Substituted phenols as pollutants that affect membrane fluidity J Environ Biol 29 2008 733 738
239. J.D. Martins, A.S. Jurado, A.J.M. Moreno, and V.M.C. Madeira Comparative study of tributyltin toxicity on two bacteria of the genus Bacillus Toxicol Vitro 19 2005 943 949
240. E. Zsigmond, and M.T. Clandinin Modulation of mitochondrial ATPase sensitivity to inhibitors and stimulators by diet-induced changes in membrane lipid Int J Biochem 18 1986 505 511
241. J.P. Monteiro, P.J. Oliveira, A.J.M. Moreno, and A.S. Jurado Disruption of hepatic mitochondrial bioenergetics is not a primary mechanism for the toxicity of methoprene - relevance for toxicological assessment Chemosphere 72 2008 1347 1354
242. A.S. Jurado, M. Fernandes, R. Videira, F. Peixoto, and V. Joaquim Herbicides: the face and the reverse of the coin. An in vitro approach to the toxicity of herbicides in non-target organisms A. Kortekamp, Herbicides and environment 2011 INTECH Vienna, Austria
243. M.A.S. Fernandes, A.S. Jurado, R.A. Videira, M.S. Santos, A.J.M. Moreno, and A. Velena Cerebrocrast promotes the cotransport of H+ and Cl- in rat liver mitochondria Mitochondrion 5 2005 341 351
244. M.A.S. Fernandes, S.P.S. Pereira, A.S. Jurado, J.B.A. Custódio, M.S. Santos, and A.J.M. Moreno Comparative effects of three 1,4-dihydropyridine derivatives [OSI-1210, OSI-1211 (etaftoron), and OSI-3802] on rat liver mitochondrial bioenergetics and on the physical properties of membrane lipid bilayers: relevance to the length of the alkoxyl chain in positions 3 and 5 of the DHP ring Chem Biol Interact 173 2008 195 204
245. C. Luxo, A.S. Jurado, and V.M. Madeira Toxicity assessment of tamoxifen by means of a bacterial model Appl Biochem Biotechnol 87 2000 219 232
246. M.M. Donato, A.S. Jurado, M.C. Antunes-Madeira, and V.M. Madeira Membrane lipid composition of Bacillus stearothermophilus as affected by lipophilic environmental pollutants: an approach to membrane toxicity assessment Arch Environ Contam Toxicol 39 2000 145 153
247. S.P. Pereira, M.A. Fernandes, J.D. Martins, M.S. Santos, A.J. Moreno, and J.A. Vicente Toxicity assessment of the herbicide metolachlor comparative effects on bacterial and mitochondrial model systems Toxicol Vitro 23 2009 1585 1590
248. P.V. Escribá Membrane-lipid therapy: a new approach in molecular medicine Trends Mol Med 12 2006 34 43
249. J.A. Lundbaek Lipid bilayer-mediated regulation of ion channel function by amphiphilic drugs J Gen Physiol 131 2008 421 429
250. O.S. Andersen, and R.E. Koeppe Bilayer thickness and membrane protein function: an energetic perspective Annu Rev Biophys Biomol Struct 36 2007 107 130
251. J.A. Lundbaek, P. Birn, J. Girshman, A.J. Hansen, and O.S. Andersen Membrane stiffness and channel function Biochemisty 35 1996 3825 3830
252. J.A. Lundbaek, P. Birn, A.J. Hansen, R. Sogaard, C. Nielsen, and J. Girshman Regulation of sodium channel function by bilayer elasticity J Gen Physiol 123 2004 599 621
253. G. Szabo, A. Dolganiuc, Q. Dai, and S.B. Pruett TLR4, ethanol, and lipid rafts: a new mechanism of ethanol action with implications for other receptor-mediated effects J Immunol 178 2007 1243 1249
254. G. Paradies, G. Petrosillo, V. Paradies, R.J. Reiter, and F.M. Ruggiero Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease J Pineal Res 48 2010 297 310
255. 2+ activation of PDH Am J Physiol 276 1999 H149 H158
256. D. Ardail, J.P. Privat, M. Egretcharlier, C. Levrat, F. Lerme, and P. Louisot Mitochondrial contact sites - lipid-composition and dynamics J Biol Chem 265 1990 18797 18802